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Intraventricular adrenal medulla grafts were found 
to produce dissociable effects on rotational behavior in- 
duced by amphetamine and apomorphine in rats with 
unilateral striatal dopamine depletions. Some animals 
showed a decrease in the behavioral response to apo- 
morphine, some showed a decrease to amphetamine, 
and some showed a decrease to both amphetamine and 
apomorphine. Using in uiuo microdialysis, the experi- 
ments reported demonstrate that in animals with de- 
creased rotational behavior, assessed with either am- 
phetamine or apomorphine, there was an increase in 
the permeability of the blood-brain barrier to dopa- 
mine. The increased blood-brain barrier permeability 
was visually confirmed with horseradish peroxidase. 
The extent of the blood-brain barrier disruption, how- 
ever, was greater in animals with a decreased response 
to amphetamine. Animals that exhibited decreased am- 
phetamine-induced turning after adrenal medulla 
grafts also had a greater amphetamine-stimulated in- 
crease in striatal dopamine and greater extracellular 
striatal dihydroxyphenylacetic acid concentrations 
compared to controls and animals with a graft-induced 
decrease in the response to apomorphine. We conclude 
that more than one mechanism is involved in mediating 
the behavioral effects of adrenal medulla grafts. o 1991 
Acedernie Prem, Inc. 
INTRODUCTION 
Autografts of adrenal medulla tissue have been used 
as a treatment for patients with intractable Parkinson’s 
disease (PD). The first reports of successful adrenal 
medulla grafts in patients with PD received consider- 
able attention but subsequent studies have been less 
optimistic about the usefulness of the procedure (for 
review see Refs. (3, 14)). In general, the latest reports 
suggest that intracerebral autografts of adrenal medulla 
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tissue produce modest improvement, at best, in patients 
with PD (1,15). These findings suggest that further ex- 
perimentation is needed to determine the factors that 
influence the behavioral effectiveness of adrenal me- 
dulla grafts. 
Clinically, PD is characterized by resting tremor, mus- 
cular rigidity, and akinesia (26). Bilateral striatal dopa- 
mine (DA) denervation in rats produces a syndrome 
that is akin to PD in humans. The symptoms of this 
syndrome include akinesia, rigidity, and abnormal pos- 
ture (26,27). Unilateral striatal DA denervation in rats 
produces a movement disorder that has been used exten- 
sively as an animal model of PD since the deficits are 
relatively easy to quantify. These deficits include contra- 
lateral sensorimotor neglect, contralateral resting 
tremor, and drug-induced rotational behavior (10, 19, 
28,29). It is the drug-induced rotational behavior, how- 
ever, that has been primarily used for evaluating graft 
effectiveness in this animal model of PD. 
Drugs that stimulate DA activity produce rotational 
behavior in the unilateral DA-denervated rat. Amphet- 
amine (AMPH), for example, induces DA release and 
decreases DA uptake at presynaptic terminals. This re- 
sults in ipsiversive rotational behavior due to the asym- 
metry in DA release between the intact and the dener- 
vated striatum (21, 22, 29). In contrast, apomo~hine 
(APO), a DA agonist, induces rotational behavior in the 
direction contralateral to the striatal DA denervation. 
This contraversive turning has been attributed to the 
postsynaptic DA receptor supersensitivity that occurs 
following DA denervation of the striatum (11,28). Intra- 
ventricular adrenal medulla grafts decrease the rota- 
tional behavior induced by AMPH or APO in rats with 
unilateral striatal DA denervation (5,13). The decrease 
in the turning behavior is interpreted as decreased 
asymmetry or normalization of function and is used as 
an index of behavioral recovery of function. 
The implicit assumption, to date, has been that 
AMPH- and APO-induced rotational behaviors are in- 
terchangeable measures of the asymmetry in striatal 
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DA function. In a recent study from our laboratory, how- 
ever, we found that there are differential changes in the 
behaviors induced by these two drugs following adrenal 
medulla grafts (2). In other words, some animals 
showed a decreased behavioral response to both AMPH 
and APO, but other animals with adrenal medulla grafts 
exhibited a decreased response exclusively to AMPH or 
APO. This suggests that there are distinct mechanisms 
involved in mediating the graft-induced behavioral 
changes in response to AMPH and APO. Since the pri- 
mary mechanisms by which AMPH and APO induce 
rotational behavior are quite different, it is possible that 
adrenal medulla grafts can affect these two behaviors 
via independent processes. 
It was originally hypothesized that adrenal medulla 
grafts promote recovery via the diffuse release of cate- 
cholamines into the surrounding cerebrospinal fluid 
(CSF) and the paraventricular brain tissue. DA is not 
detectable within the CSF following behaviorally effec- 
tive adrenal medulla grafts in rats, however, suggesting 
that some other mechanism(s) is involved (5). A study 
by Becker and Freed (5) has found that there are 
changes in striatal DA metabolism and AMPH-induced 
DA release associated with adrenal medulla grafts that 
result in decreased AMPH-induced turning. It seems, 
therefore, that some behaviorally effective adrenal me- 
dulla grafts supply and/or facilitate striatal DA func- 
tion. One possible mechanism that could be responsible 
for this is a compromised blood-brain barrier (BBB) 
that allows catecholamines from the graft and/or the 
periphery to gain access to the denervated striatum. 
This idea is supported by experiments that show the 
blood vessels from surviving adrenal medulla grafts 
anastomos with the host blood vessels while retaining 
the permeability of peripheral tissue (25). Furthermore, 
there is an increase in serum DA in rats with adrenal 
medulla grafts that is correlated with decreased APO- 
induced turning (5). Therefore, DA released by the 
grafted chromaffin cells may enter the vascular system 
and gain access to the adjacent host brain through a 
compromised BBB. What remains to be determined is 
the relationship between the disruption of the BBB fol- 
lowing adrenal medulla grafts and behavioral recovery. 
The present study uses behavioral, neurochemical, 
and histological techniques to examine the underlying 
neurological processes associated with specific behav- 
ioral profiles following intraventricular adrenal medulla 
grafts. Extracellular striatal DA concentrations were 
assessed using in vivo microdialysis within the dener- 
vated striatum of rats with adrenal medulla grafts that 
resulted in decreased rotational behavior induced by 
AMPH or APO. The integrity of the BBB was analyzed 
in these animals to determine if a compromised BBB 
was associated with graft-induced changes in behavior 
and/or striatal DA activity. We report that behavioral 
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FIG. 1. The effect of adrenal medulla or control grafts on (A) 
AMPH- and (B) APO- induced rotational behavior expressed as % 
change from pregraft (mean f SEM). All animals that showed at 
least a 10% decrease in a drug-induced behavior were considered to 
express recovery in response to that drug. *Following intraventricular 
adrenal medulla grafts there was a significant decrease from pregraft 
rotational behavior (P < 0.009). tFollowing intraventricular adrenal 
medulla grafts or control grafts there was a significant increase in 
AMPH-induced rotational behavior compared to pregraft (P -C 0.05). 
recovery is associated with increased permeability of 
the BBB to DA. 
MATERIALS AND METHODS 
Experimental Animals, Surgery, and Rotational Tests 
Adult female Long-Evans rats (180-200 g) were 
maintained on a 14:lO [light:dark] cycle with food and 
water continuously available. One group (n = 16) of rats 
was ovariectomized (OVX) to minimize the variation in 
drug-induced rotational behavior that is seen over the 
estrous cycle (7). A second group of rats (n = 24) was not 
OVX due to the excessive weight gain that occurred in 
the first group that lead to difficulty in handling. Intact 
and OVX rats were equally represented in all treatment 
groups and there was no effect of OVX on the results. 
The results from these two groups were, therefore, com- 
bined for all analyses reported here. All procedures were 
carried out according to an approved University Com- 
mittee on Use and Care of Animals protocol. 
Animals were tested for rotational bias during two l-h 
tests in automated rotometers with 0.85 mg/kg AMPH 
(ip). The animals then received an injection of 6-hy- 
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TABLE 1 
Pregraft Rotational Behavior 
3.0 mgfkg AMPH’ 0.1 mgfkg APOb 
Group mean + SEM mean f SEM 
AMPH RECOV (n = 6) 2214.89 + 456.58 382.00 5~ 125.58 
APO RECOV (n = 16) 1945.00 f 216.12 515.91 * 70.40 
No recovery (n = 10) 2104.68 & 197.62 309.15 * 35.74 
Control (n = 8) 1577.26 f 292.68 374.23 f 71.31 
’ Total number of rotations (360” turns) made in a Z-h test session. 
b Total number of rotations made in a l-h test session. 
droxydopamine-HBr (8 yg14 ~1 at 0.5 pl/min) into the 
substantia nigra (SN) contralateral to the preferred di- 
rection of rotation during the two AMPH tests (i.e., a 
lesion of the dominant nigrostriatal pathway) as de- 
scribed previously (22). Two weeks following the unilat- 
eral SN lesion, rats underwent two l-h rotational tests 
with 0.25 mg/kg apomorphine (SC) and two l-h tests 
with 0.85 mg/kg AMPH (ip). Those rats that rotated 
greater than 100 contraversive 360 degree turns follow- 
ing APO and greater than 50 ipsiversive turns following 
AMPH were used in this study. Previous studies have 
demonstrated that animals meeting these criteria have 
greater than 90-95% DA depletions (18,22). To prevent 
confounding behavioral effects due to the sensitization 
to AMPH (23), the 40 rats that met criteria were given 
injections of 5.0 mg/kg AMPH each weekday for 2 
weeks and then withdrawn from the drug for 3 weeks. 
Following the sensitization to AMPH, the rats under- 
went pregraft rotational behavior testing with 0.1 mg/ 
kg APO (SC). At least three and no more than six l-h 
APO tests separated by 48 h were conducted until the 
rotational behavior stabilized. The same schedule was 
then used to test with 3.0 mg/kg AMPH (ip; 2-h tests). 
The number of turns induced during the last three test 
sessions with each drug was used to calculate the mean 
baseline rate for APO- and AMPH-induced rotational 
behavior for each animal. 
Graft Procedure 
Following pregraft rotational testing, animals re- 
ceived intraventricular grafts of adrenal medulla tissue 
(n = 32), adrenal cortex tissue (n = 6), or a sham graft 
(eannula was lowered but no tissue ejected, n = 2). Adre- 
nal medulla and adrenal cortex tissue was obtained 
from female Long-Evans rats. The donors received an 
overdose of sodium pentobarbital and the adrenals were 
removed under aseptic conditions. Prior to transplanta- 
tion the hosts were anesthetized with 30 mg/kg sodium 
pentobarbital and supplemented with methoxyflurane. 
Using standard stereotaxic techniques and under asep- 
tic/sterile conditions, a small burr hole was drilled in 
the skull over the lateral ventricle adjacent to the dener- 
vated striatum (4). Pieces of adrenal medulla or adrenal 
cortex tissue were aspirated into a 21-gauge injection 
cannula. The cannula was lowered (from skull flat) 5.3 
mm to punch through the wall of the ventricle and was 
then raised 0.5 mm. A Teflon plunger was used to push 
the tissue out of the cannula. Thirty animals received 
either adrenal medulla tissue (n = 24) or adrenal cortex 
tissue (n = 6) from two to four adrenals obtained from 
2-month-old female donors. Eight rats received adrenal 
medulla tissue from donors less than l-month-old 
(these grafts were equally effective and are treated the 
same as the older donor tissue in subsequent analyses). 
* 
0 20 40 60 8b 1;rO Ii'0 li0 160 
TIME 
FIG. 2. Baseline and AMPH-stimulated extracellular striatal 
DA concentrations (fmol/min) in AMPH RECOV (filled circles), 
APO RECOV (open circles), no recovery (filled squares), and control 
animals (open squares). (A) AMPH RECOV animals tended to have 
higher basal extracellular DA concentrations within the denervated 
striatum than animals in the other three groups, but this difference 
did not reach statistical significance. (B) Extracellular striatal DA 
concentrations during baseline (0 min) and eight ZO-min dialysate 
samples following 3.0 mglkg AMPH. There was a significant differ- 
ence in AMPH-stimulated DA release among the four groups. This 
was indicated by a significant main effect of group (F(3,26) = 3.924, P 
= 0.0195), an effect of time (F(3,8) = 27.846, P = O.OOOl), and a group 
by time interaction (F(8, 24) = 3.634, P = 0.0001). *AMPH RECOV 
rats had significantly (P < 0.05) greater extracellular striatal DA con- 
centrations than APO RECOV, no recovery, and controls. tAMPH 
RECOV rats had significantly greater extracellular striatal DA con- 
centrations than controls and animals with no recovery (P < 0.05). 
BBB PERMEABILITY AND ADRENAL MEDULLA GRAFTS 187 
- . 
gf S- 
1350 
B* 
1200 
n s -5 1050 
2 g - 900 
= ii, 750 
0 20 40 60 80 100 120 140 160 
TJME 
FIG. 3. Baseline and AMPH-induced extracellular DOPAC con- 
centrations (fmob’min) within the denervated striatum of AMPH 
RECOV (filled circles), APO RECOV (open circles), no recovery 
(filled squares), and control animals (open squares). (A) There was a 
significant effect of group on baseline extracellular DOPAC (F(3,26) 
= 7.689, P = 0.0008). *DOPAC concentrations within the denervated 
striatum of AMPH RECOV rats were significantly greater than the 
other three groups (P < 0.01). (B) Extracellular striatal DOPAC con- 
centrations were significantly different among groups during baseline 
(0 min) and following AMPH treatment. This difference was indi- 
cated by a significant main effect of group (F(3, 26) = 5.586, P 
= 0.004) as well as an effect of time (F(3,8) = 17.782, P = 0.0001) and 
a group by time interaction (F(8, 24) = 6.663, P = 0.0001). *AMPH 
RECOV animals had significantly higher extracellular DOPAC con- 
centrations within the denervated striatum compared to the other 
three groups (P < 0.05). 
Beginning 6 weeks postgraft, animals were tested 
once a week with 0.1 mg/kg APO (l-hour test) and 48 h 
later with 3.0 mg/kg AMPH (2-h test). Sixteen of the 
rats were tested every 2 weeks until 22 weeks postgraft. 
This extended test period allowed us to examine the 
stability of behavioral changes observed following intra- 
ventricular adrenal medulla grafts. The changes in ro- 
tational behavior stabilized by 10 weeks postgraft. The 
remaining 26 rats were, therefore, tested weekly with 
each drug until 10 weeks postgraft. The mean of the 
number of turns induced in the last three behavioral 
tests postgraft was compared with the pregraft mean to 
calculate the percentage change in rotational behavior 
([postgraft - pregraft/pregraft) X 100%). 
In uiuo ~icrodial~s~s 
Thirty of the forty experimental animals used in the 
behavioral experiments described above underwent in 
uiuo microdialysis (some animals died during surgery 
and others had malfunctioning dialysis probes on the 
day of dialysis). Following the last postgraft rotational 
test, 13 animals received implants of a unilateral guide 
cannula aimed at the denervated striatum and 17 ani- 
mals received bilateral guide cannulae aimed at both the 
intact and the denervated striatum. At least 1 week 
later, the rats were anesthetized with sodium pentobar- 
bital, received a jugular catheter, and the dialysis 
probe(s) was lowered through the guide cannula(e) into 
the striatum. The dialysis probe was of a concentric de- 
sign and consisted of a 4-mm long dialysis membrane 
with a 250qm outer diameter (MW cutoff = 6000) as 
previously described (24). Sixteen to eighteen hours fol- 
lowing implantation, the dialysis experiments began 
(flow rate = 1.5 plfmin). Samples were collected at 20- 
min intervals throughout the experiment. Baseline sam- 
ples were taken until stable extracellular striatal DA 
concentrations were obtained. All samples were ana- 
lyzed for DA, dihydroxyphenylacetic acid (DOPAC), 
homovanillic acid (HVA), and Shydroxyindoleacetic 
acid (SHIAA) using HPLC-EC as described elsewhere 
(4). Animals then received an injection of 3.0 mglkg 
AMPH (ip) and dialysate samples were collected for an 
additional 160 min. 
Dopamine Penetration into Striatum 
Twenty-five of the 30 rats above (5 rats lost their jugu- 
lar catheters) plus 19 rats from a previous study (3) that 
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FIG. 4. Extracellular DA concentrations within the denervated 
striatum adjacent to behaviorally effective and ineffective adrenal 
medulla grafts, control grafts, or within the intact striatum of animals 
with bilateral dialysis probes, following a peripheral bolus of 200 pg 
DA. There was a 1078% i 193% (mean f SEM) increase in extracel- 
lular DA compared to baseline within the denervated striatum of rats 
with AMPH RECOV. APO RECOV rats had a 561% ~?r 130% increase 
in extracellular striatal DA compared to baseline. **Following a pe- 
ripheral bolus of DA, the increase in extracellular striatal DA concen- 
tration was significantly higher than in all other groups (P < 0.01). 
*Following a peripheral bolus of DA, the increase in extracellular 
striatal DA concentration was significantly greater than that in the 
intact striatum (P i 0.05). 
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were treated similarly, were involved in a second dialy- 
sis experiment that followed the administration of 
AMPH to stimulate DA release. Within 2 h after the 
last AMPH sample, rats received an injection of 30 mgl 
kg sodium pentobarbital and 0.2 mg haloperidol 
through the jugular catheter. Two lo-min dialysate sam- 
ples were collected and used as baseline samples. The 
animals then received an intrajugular injection of 200 pg 
DA in 100 ~1 Ringer’s to determine if the BBB had be- 
come permeable to DA. Samples were collected 5,10,20, 
and 30 min after the DA injection and analyzed for DA 
in animals with behaviorally effective (n = 25) or inef- 
fective (n = 11) adrenal medulla grafts or control grafts 
(n = 8). In addition, extracellular DA concentrations 
were monitored in the contralateral intact striatum of 
15 rats. 
HRP Penetration into Striatum 
Six animals, four with adrenal medulla grafts, one 
with an adrenal cortex graft, and one with a unilateral 
SN lesion but no graft, were analyzed for BBB perme- 
ability to a systemic injection of horseradish peroxidase 
(HRP). One of the animals with an adrenal medulla 
graft expressed a graft-induced decrease in AMPH-in- 
duced turning, two expressed a decrease in APO-in- 
duced turning, and one expressed no behavioral recov- 
ery. The six animals were anesthetized, the femoral vein 
was exposed, and a bolus of horseradish peroxidase 
(Sigma type VI; 1 mg/5 g body wt dissolved in 0.7 ml 
Ringer’s) was injected. Thirty minutes later, 0.9% saline 
was perfused transcardially, followed by 3% glutaralde- 
hyde (500 ml over 30 min), and then 10% sucrose-buffer 
(500 ml over 30 min at 4’C). The brains were removed 
immediately and stored in sucrose-buffer (4’C) for no 
more than 2 days. Twenty-micrometer sections were cut 
on a cryostat at -14°C and thaw mounted onto chrom- 
alum-subbed slides. The sections were incubated for 
HRP reaction product with 3,3’-diaminobenzidine 
(DAB) and/or tetramethylbenzidine 
RESULTS 
Rotational Behavior 
(TMB) (16, 20). 
As we have shown previously, adrenal medulla grafts 
induced differential changes in the behavioral response 
to AMPH and APO. Some animals showed adrenal me- 
dulla graft-induced recovery as indicated by a decrease 
in the behavioral response to AMPH and APO (n = 3). 
However, some animals expressed decreased AMPH- 
induced turning exclusively (n = 3), some expressed de- 
creased APO-induced turning exclusively (APO RE- 
COV; n = 16), while others showed no recovery (n = 10). 
The effect of adrenal medulla or control grafts on 
AMPH- and APO-induced rotational behavior is illus- 
trated in Fig. 1. Animals that showed at least a 10% 
decrease in either drug-induced turning behavior were 
considered to have behavioral recovery. The six animals 
that showed a decrease in the response to AMPH are 
considered to be one group throughout the remainder of 
this paper (AMPH RECOV; n = 6). As shown in Table 
1, the behavioral response to AMPH and APO prior to 
the grafts was not significantly different among the four 
groups. 
In vivo Microdialysis 
As determined by in vivo microdialysis, the AMPH- 
stimulated increase in extracellular DA within the de- 
nervated striatum was significantly potentiated in 
AMPH RECOV rats versus APO RECOV, no recovery, 
or control animals (Fig. 2B). The baseline extracellular 
striatal DA concentrations also tended to be higher in 
the striatum of AMPH RECOV rats compared with the 
other three groups although this was not a statistically 
significant effect (Fig. 2A). By contrast, baseline con- 
centrations of extracellular striatal DOPAC were signifi- 
cantly greater in AMPH RECOV rats than in APO RE- 
COV, no recovery, or control groups (P < 0.01; Fig. 3A). 
This difference was maintained even after AMPH 
treatment which produced a steady decline in extracel- 
lular DOPAC concentrations in all groups (Fig. 3B). 
Dopamine Penetration into Striatum 
The average striatal extracellular DA concentrations 
following a peripheral bolus of DA (200 pg) were in- 
creased lo-fold in AMPH RECOV rats within the first 
two 5-min dialysate samples (Fig. 4). This increase was 
significantly higher than baseline (P = 0.005) and was 
greater than the increase found in any other group, or 
the contralateral intact striatum (P < 0.01). A periph- 
eral bolus of DA also resulted in a large increase in 
striatal extracellular DA concentrations in APO RE- 
COV animals (560% f 130%). This increase was signifi- 
cantly greater than baseline (P = 0.008) or the increase 
seen in the intact striatum (P < 0.05). There was a slight 
FIG. 5. HRP (DAB reaction) penetration into intraventricular adrenal medulla grafts and the adjacent denervated striatum in an APO 
RECOV animal (A, x200 original negative magnification) and an AMPH RECOV animal (B; x200). No reaction product is visible in the left 
ventricle or the intact striatum in an APO RECOV animal although it is visible in the graft and denervated striatum (C; x40). HRP reaction 
product is visible within the adrenal medulla graft and surrounding host tissue of an animal with no recovery, but the graft is located caudal to 
the intended graft site and is not adjacent to the denervated striatum (D; x40). Abbreviations: striatum (S), lateral ventricle (V), and 
triangular septal nucleus (T’S). 
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but significant increase in extracellular DA concentra- 
tions within the denervated striatum of rats with no 
recovery when compared to baseline (P = 0.03). There- 
fore, while the BBB was apparantly compromised in all 
groups that had received adrenal medulla tissue 
implants, animals with grafts that were behaviorally 
effective showed the greatest permeability of DA into 
striatum. 
HRP Penetration into Striatum 
The disruption of the BBB following peripheral tissue 
grafts, demonstrated by the DA infusion data, was vi- 
sually confirmed with HRP. Animals with behaviorally 
effective grafts (AMPH RECOV and APO RECOV) 
that showed an increase in striatal extracellular DA fol- 
lowing the peripheral bolus also showed HRP reaction 
product within the graft that extended into the adjacent 
denervated striatum (Figs. 5A and 5B). The contralat- 
era1 intact striatum of these animals was devoid of reac- 
tion product (Fig. 5C). In the lesion-only and cortex- 
grafted control rats (data not shown), there was no 
HRP reaction product visible within either striatum, 
while in the animal with no recovery the adrenal me- 
dulla graft was found caudal to the intended graft site 
(Fig. 5D). 
DISCUSSION 
Permeability of the BBB to DA and HRP was found 
to be associated with behaviorally effective adrenal me- 
dulla grafts. Beneficial effects of adrenal medulla grafts, 
as indicated by decreased turning induced by either 
AMPH or APO, were also found to be associated with 
specific neurochemical changes in the DA-denervated 
striatum adjacent to the grafts. Animals that had an 
improvement in the behavioral response to AMPH had 
an enhanced AMPH-induced increase in extracellular 
striatal DA and increased baseline concentrations of 
DOPAC indicating that the functional activity of DA in 
the striatum of these animals was increased. These neu- 
rochemical changes were not seen in animals with de- 
creased APO-induced rotational behavior. We suggest 
that further analysis of the neurological changes asso- 
ciated with specific behavioral profiles induced by intra- 
cerebral transplantation procedures will contribute to 
our understanding of the mechanisms mediating recov- 
ery of function. 
The increase in extracellular striatal DA adjacent to 
the graft following peripheral DA administration in 
AMPH RECOV animals was significantly greater than 
the increase seen in all other groups. AMPH RECOV 
animals also had enhanced functional DA activity in the 
striatum. Whether this is due to the compromised BBB 
has not been determined. Additional gram-induced 
changes may be necessary to produce the increase in 
striatal DA activity. A feasible explanation, however, is 
that DA and DOPAC from the graft gain access to the 
striatum via the compromised BBB. AMPH could then 
induce DA release from the grafted chromaffin cells 
which would have access to the denervated striatum to 
decrease the asymmetry in striatal DA release. While 
we do not know that the DA detected in striatum was 
produced by the graft, previous reports have shown that 
adrenal medulla grafts contain DA (4). These results 
suggest that a dopaminergic mechanism mediates the 
behavioral results reported for AMPH RECOV. 
Studies using intrastriatal fetal mesencephalic tissue 
grafts have also found a correlation between an increase 
in striatal DA activity and a decrease in the behavioral 
response to AMPH (9, 30). These findings lend strong 
support for a dopaminergic mechanism involved in de- 
creased AMPH-induced turning following fetal mesen- 
cephalic grafts and this corresponds with the present 
results as well as previous findings with adrenal medulla 
grafts (5). The mechanism(s) by which the two graft 
paradigms produce an increase in striatal DA activity, 
however, may be different. The reinnervation of the 
host striatum by fetal mesencephalic grafts has been 
associated with the increase in striatal DA activity and a 
decrease in AMPH-induced rotational behavior (9). In 
contrast, the present findings suggest that adrenal me- 
dulla graft-induced changes in the BBB are associated 
with the increase in striatal DA activity and AMPH 
RECOV. 
The decrease in the behavioral response to APO fol- 
lowing adrenal medulla grafts suggests that there is a 
decrease in the postsynaptic DA receptor supe~ensitiv- 
ity that occurs following striatal DA denervation. It is 
still unclear whether the decrease in APO-induced rota- 
tional behavior following adrenal medulla grafts is asso- 
ciated with a decrease in postsynaptic DA receptor su- 
persensitivity, although a decrease in the receptor super- 
sensitivity has been found to occur following fetal 
mesencephalic grafts (12). Experiments that provided 
exogenous DA to the denervated striatum have demon- 
strated that increasing striatal DA can decrease APO- 
induced rotational behavior (6, 17). The present find- 
ings, however, do not support a theory involving a 
purely dopaminergic mechanism underlying adrenal 
medulla graft-induced APO RECOV. 
Despite the fact that striatal DA activity was en- 
hanced in AMPH RECOV animals, and that extracellu- 
lar DA tended to be increased, the response to APO was 
not affected in all of these animals. This suggests that 
an increase in extracellular DA is not sufficient to de- 
crease DA receptor supersensitivity. A further dissocia- 
tion of the postsynaptic supersensitivity from extracel- 
lular DA concentrations is seen in the APO RECOV 
animals. These animals had decreased APO-induced 
turning, but extracellular DA concentrations were not 
enhanced. Furthermore, since the grafts were located in 
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the ventricle, nonspecific damage to the striatum that 
results in the destruction of striatal cells with DA recep- 
tors is an unlikely mechanism underlying the decrease 
in APO-induced turning. 
The apparent lack of DA involvement in adrenal me- 
dulla graft-induced APO RECOV indicates that this 
type of recovery may actually be detrimental. For exam- 
ple, previous work by Marshall and colleagues (19) sug- 
gests that the postsynaptic DA receptor supersensitiv- 
ity is important for producing spontaneous recovery of 
sensorimotor deficits following unilateral striatal DA de- 
nervation. A decrease in the postsynaptic supersensitiv- 
ity could, therefore, result in an increase in sensorimo- 
tor deficits in the absence of an increase in striatal DA 
activity. In a clinical setting, a decrease in the postsyn- 
aptic DA receptor supersensitivity without an increase 
in striatal DA activity could lead to a decrease in a pa- 
tients response to therapeutic drugs such as levodopa 
and DA agonists. 
APO RECOV animals did express a waft-induced in- 
crease in the permeability of the BBB to DA. This sug- 
gests that the BBB may also play a role in the decrease 
in APO-induced rotational behavior following adrenal 
medulla grafts. The increase in striatal DA after periph- 
eral DA administration that was seen in APO RECOV 
rats, however, was significantly lower than the increase 
seen in AMPH RECOV rats. The difference in the ex- 
tent of BBB disruption and/or the location of the graft 
relative to the striatum may dissociate AMPH RECOV 
and APO RECOV by influencing the access of DA and/ 
or other peripheral agents to the denervated striatum. 
Future research will examine these possibilities. 
The integrity of the BBB in the three control groups 
reinforces the link between BBB disruption and recov- 
ery of function following adrenal medulla grafts. The 
increase in BBB permeability to DA in animals with no 
recovery following adrenal medulla grafts was signifi- 
cantly less than that seen in animals with behaviorally 
effective grafts. The lack of a behavioral effect in the no 
recovery group may be due to poor graft survival and/or 
placement so that there was only marginal BBB perme- 
ability. It should be noted that no significant increase in 
extracellular DA was found within the intact striatum 
following peripheral DA administration. Similarly, no 
visible HRP reaction product was seen in the intact 
striatum, indicating that the insertion of the microdial- 
ysis probe did not disrupt the BBB. This is in agreement 
with a previous study that has demonstrated that the 
BBB is intact within 30 min following probe insertion 
(8). Animals that received intraventricular adrenal cor- 
tex grafts would also be expected to have a disrupted 
BBB. In fact, one animal with an adrenal cortex graft 
did show a large increase in extracellular striatal DA 
concentrations following the peripheral bolus of DA. 
This same animal also expressed a greater than 10% 
decrease in APO-induced rotational behavior. Most an- 
imals with cortex grafts, however, did not show this ef- 
fect, perhaps because the graft location and/or survival 
tended to be more variable in these animals. This find- 
ing further supports the theory that BBB disruption is 
associated with APO RECOV and that there may be 
nondopaminer~~ mechanisms involved. 
In conclusion, intraventricular adrenal medulla 
grafts produce dissociable effects on AMPH- and APO- 
induced rotational behavior that are associated with 
differences in the permeability of the BBB to DA. The 
ability of peripheral DA to gain access to the denervated 
striatum is greater in AMPH RECOV animals than in 
APO RECOV animals. In addition, this more extensive 
permeability to DA is associated with an increase in 
striatal DA activity in the AMPH RECOV group. The 
adrenal medulla graft-induced APO RECOV, however, 
appears to involve a distinct mechanism(s) that may not 
involve DA. Trophic mechanisms and/or the involve- 
ment of other graft derived substances that were not 
measured in the present study could be responsible for 
APO RECOV. Future studies need to explore possible 
avenues for increasing the percentage of animals that 
express AMPH RECOV since the dopaminergic mecha- 
nism involved in this type of recovery may be more ben- 
eficial when extrapolated to a clinical setting. 
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